Yahoo Web Search

Search results

  1. May 2, 2024 · Moderna Chief Executive Officer Stéphane Bancel talks about how the biotech giant is cutting costs and developing new vaccines. The drugmaker expects to have its vaccine for respiratory...

    • 8 min
  2. May 9, 2024 · Moderna chief executive Stéphane Bancel has focused solely on mRNA technology in vaccine development. Adam Glanzman/Photographer: Adam Glanzman/Bloo. Moderna’s pioneering COVID shot turned the...

  3. 3 days ago · Last year Distillations talked to people who have special insight into the coronavirus crisis (../../../distillations/pandemic-perspectives) —biomedical rese...

  4. People also ask

  5. May 2, 2024 · “This is the start of a banner year for our vaccine platform as we continue to advance mRNA medicines for patients,” said Moderna CEO Stéphane Bancel in the earnings report.

  6. May 2, 2024 · "As we anticipate the launches of our Spikevax 2024-2025 formula and RSV vaccine, we are exercising financial discipline and have intensified our focus on building and utilizing AI technologies to further streamline operations and enhance productivity," said Stéphane Bancel, Chief Executive Officer of Moderna.

  7. May 2, 2024 · On today's call are Stéphane Bancel, our Chief Executive Officer; Stephen Hoge, our President; and Jamey Mock, our Chief Financial Officer.

  8. May 2, 2024 · Moderna respiratory syncytial virus mRNA vaccine development drug launch Earnings Stéphane Bancel COVID-19 Marketing. Moderna expects initial approvals of its RSV vaccine to start rolling in...

  1. People also search for